Eric Francois insider trades
Open-market stock purchases and sales by Eric Francois, Director at Cero Therapeutics Holdings, Inc, from SEC Form 4 filings since Nov 2, 2015.
Track record: 80% of 5 scored buys are up 5% or more since purchase, averaging +114%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 4, 2026 | CERO Cero Therapeutics Holdings, Inc | Bought (not open market) | — |